Vaxcellbio's experimental natural killer (NK) cell therapy, VCB-1102, combined with hepatic arterial infusion chemotherapy ...

Only 19.3 percent of patients referred from tertiary general hospitals were confirmed to have received follow-up care at ...

AriBio said Friday it will release topline results from its global phase 3 trial of oral Alzheimer’s disease drug candidate ...

Mold-covered walls, cockroach-infested rooms and patients with limited mobility who cannot even contemplate visiting a ...

LigaChem Biosciences has dosed the first patient in a global phase 1/2 trial of LCB02A, its experimental antibody-drug ...

Nearly 30,000 people in Korea have type 1 diabetes, with adults accounting for more than 70 percent of newly diagnosed cases, ...

SEERS has received ethics approval in Abu Dhabi to begin a pilot of its AI-based arrhythmia screening service, a final step ...

The government has added seven hereditary disorders to the list of conditions eligible for genetic testing in embryos and ...

Recurrent ischemic strokes in patients with cervicocephalic artery dissection occur predominantly within the first week after ...

Sky Labs said Friday that more patients reached their target blood pressure (BP) when doctors adjusted medication using its ...

AI in clinical trials is moving beyond routine task automation toward integrated platforms that connect workflows, improve ...

The Ministry of Food and Drug Safety (MFDS) said Thursday it had approved Jascayd (nerandomilast), a treatment for idiopathic ...